phrykt

Nutex Health Inc. (NUTX): who owns it and who trades it

As of Nov 16, 2026, NUTX insiders reported 1 open-market sale worth $43.5K and 5 purchases worth $148K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Scott J Saunders (Director), with $43.5K. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Nutex Health

From the latest filings

Overall: about as much buying as selling. Famous investors mostly sold. Funds and insiders mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns NUTX

154 funds and institutions reported NUTX shares worth $503M at the end of Q2 2026, about 43% of the company. The largest holder is Pertento Partners LLP with 6.6%.

Funds and institutions (13F) 43%Everyone else 57%

10 largest owners, by share of the company

Pertento Partners LLP6.6%
BlackRock, Inc.5.9%
American Century Companies Inc3.5%
Vanguard Capital Management LLC3.1%
Geode Capital Management, LLC1.9%
State Street Corp1.9%
D. E. Shaw & Co., Inc.1.4%
UBS Group AG1.1%
Winmill & Co. Inc0.9%
Focus Partners Wealth0.9%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Pertento Partners LLP451,3106.56%$77.1M+21%
BlackRock, Inc.407,3495.92%$69.6M+7%
American Century Companies Inc237,4143.45%$40.6M+17%
Vanguard Capital Management LLC215,9193.14%$36.9M-1%
Geode Capital Management, LLC132,0491.92%$22.6M+8%
State Street Corp130,8361.90%$22.4M+6%
D. E. Shaw & Co., Inc.97,4541.42%$16.7M–
UBS Group AG77,9121.13%$13.3M+12%
Winmill & Co. Inc65,3500.95%$11.2MNo change
Focus Partners Wealth60,8810.88%$10.4M–
Millennium Management LLC52,1070.76%$8.9M-42%
Goldman Sachs Group Inc51,2440.74%$8.8M+52%
Bridgeway Capital Management, LLC46,9240.68%$8M+212%
Empowered Funds, LLC45,1770.66%$7.7M+39%
Pacer Advisors, Inc.44,6140.65%$7.6M–
Northern Trust Corp44,0560.64%$7.5M+7%
Topline Capital Management, LLC41,7640.61%$7.1M-77%
One Plus One Wealth Management, LLC40,4410.59%$6.9MNo change
Vanguard Fiduciary Trust Co35,9690.52%$6.1M+0%
Vanguard Portfolio Management LLC34,6600.50%$5.9M-13%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, NUTX insiders reported $148K of open-market purchases and $43.5K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$148K
5 trades, 5 people
Sales, 12 months
$43.5K
1 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Sep 18, 2026
Filed Sep 18, 2026

Purchases and sales by month

$45.7K$45.7KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 18, 2026Scott J SaundersDirectorSale203$214.25$43.5KForm 4
Mar 20, 2026Frank E JaumotDirectorPurchase150$93.56$14KForm 4
Mar 19, 2026Warren HosseinionPresidentPurchase252$94.07$23.7KForm 4
Mar 17, 2026Kelvin SpearsDirectorPurchase10$94.46$945Form 4
Mar 13, 2026Pamela W. MontgomeryChief Legal Officer-HealPurchase79$88.87$7KForm 4
Nov 25, 2025Jon Christian BatesCFOPurchase750$136.71$103KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Jon Christian BatesChief Financial Officer$103K–Nov 25, 2025
Scott J SaundersDirector–$43.5KSep 18, 2026
Warren HosseinionPresident, Director$23.7K–Mar 19, 2026
Frank E JaumotDirector$14K–Mar 20, 2026
Pamela W. MontgomeryChief Legal Officer-Healthcare$7K–Mar 13, 2026
Kelvin SpearsDirector$945–Mar 17, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

NUTX short interest

High short interest. 17.0% of NUTX shares are sold short: about 1 share in 6. Over the last 12 reports the number of shares short went up 27%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 1.16M NUTX shares were sold short, 17.0% of the shares outstanding, down 5.9% from the report before. At the average daily volume of 115,422 shares, buying them all back would take about 10.1 trading days (days to cover).

Shares short, % of all shares

17.0%May 15Oct 3019.0%

Days to cover

10.1May 15Oct 3010.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.16M17.01%-6%115,42210.1
Oct 15, 20261.24M18.07%-1%163,5617.6
Sep 30, 20261.25M18.26%+1%152,5978.2
Sep 15, 20261.23M18.02%+6%164,0697.5
Aug 31, 20261.16M16.98%+3%134,4268.7
Aug 14, 20261.13M16.50%+2%193,8905.8
Jul 31, 20261.10M16.05%+5%122,1589.0
Jul 15, 20261.05M15.26%-5%137,8517.6
Jun 30, 20261.11M16.08%-1%123,2879.0
Jun 15, 20261.12M16.21%+5%134,1708.3
May 29, 20261.07M15.48%+16%124,2628.6
May 15, 2026916,30813.32%-8%181,8815.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Nutex Health company events

Nutex Health filed 15 reports on Form 8-K in the last 12 months, 1 of them about an important change (cyberattack). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Sep 11, 2026AnnouncementResults of Operations and Financial Condition. Filing
  3. Aug 31, 2026CyberattackAs disclosed in Item 8.01 of a Current Report on Form 8-K filed with the Securities and Exchange Commission on August 24, 2026, Nutex Health Inc. became aware of unauthorized activity involving data stored on its computer network. Filing
  4. Aug 24, 2026AnnouncementNutex Health Inc. recently learned of unauthorized activity involving data stored on its computer network. Filing
  5. Aug 13, 2026AnnouncementThe Fifth Circuit Court of Appeals issued an en banc decision in Texas Medical Association v. Filing
  6. Aug 6, 2026ResultsReleased financial results. Filing
  7. Jul 21, 2026AgreementNutex Health Inc., a Delaware corporation, on July 15, 2026, entered into a First Amendment to that certain Payment Dispute Resolution Services Agreement, dated as of May 1, 2024, by and between the Company and HaloMD, L.L.C., a Delaware limited liability company. Filing
  8. Apr 30, 2026ResultsReleased financial results. Filing
  9. Apr 23, 2026VoteReported shareholder vote results. Filing
  10. Mar 5, 2026ResultsReleased financial results. Filing
  11. Nov 24, 2025AnnouncementIncluded as Exhibit 23.1 is an auditors’ consent to the incorporation by reference into certain previously filed registration statements of their report relating to the consolidated balance sheet of Nutex Health Inc. as of December 31, 2023, the related consolidated statements of operations… Filing
  12. Nov 19, 2025ResultsReleased financial results. Filing
  13. Nov 18, 2025ResultsReleased financial results. Filing
  14. Nov 18, 2025ResultsReleased financial results. Filing
  15. Nov 18, 2025ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Nutex Health financials

Famous investors that hold NUTX

2 of the 50 well-known investors we track reported holding NUTX in their latest 13F filing. The largest position is Israel Englander's, worth $2.6M.

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 202612,408$2.6M0.0%-76%
Ken Griffin · Citadel AdvisorsQ3 20265,153$1.1M0.0%-72%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named NUTX in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Topline Capital Management, LLC13G/A0.0%
Nov 16, 2026Topline Capital Management, LLC13G/A0.0%
Nov 13, 2026Pertento Partners LLP13G/A7.6%
Nov 13, 2026Pertento Partners LLP13G/A7.6%

Questions about Nutex Health Inc. (NUTX) stock

Who owns the most NUTX stock?

The largest reported owner of Nutex Health Inc. (NUTX) is Pertento Partners LLP, with 6.6% of the company. In total, 154 funds and institutions reported holding NUTX at the end of Q2 2026, together about 43% of the shares. See the largest owners.

Are NUTX insiders buying or selling?

In the last 12 months, NUTX insiders reported 5 open-market purchases worth $148K and 1 sale worth $43.5K. The latest trade was on Sep 18, 2026. See every trade.

What is the short interest in NUTX?

As of Oct 30, 2026, 1.16M NUTX shares were sold short, 17.0% of the shares outstanding, down 5.9% from the report before. At the average daily volume of 115,422 shares, buying them all back would take about 10.1 trading days (days to cover). See the history.

Which famous investors hold NUTX?

2 of the 50 well-known investors we track reported NUTX in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $2.6M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.